====== Brandie Walker ======

{{ :public_health_agencies:canada:brandie_walker_0013_cropped.jpeg?150|}}

===== Affiliations =====

==== Alberta Health Services ====

Walker is the respiratory representative on the [[AHS COVID-19 Scientific Advisory Group]] under [[Alberta Health Services]].((//2019-nCoV Scientific Advisory Group.// (2021, May 27). Alberta Health Services. https://www.albertahealthservices.ca/assets/info/ppih/if-ppih-covid-19-sag-terms-of-reference.pdf))

==== Canadian Lung Association ====

Walker is a researcher for the [[:Canadian Lung Association]]. She received the Clinician-Scientist Asthma Award, which provided her with $115,000.00 in funding from [[:AllerGen]], the Canadian Lung Association and the [[:Canadian Thoracic Society]].((//Dr. Brandie Walker.// (2014, July 25). Canadian Lung Association. https://archive.ph/DDQud))

The CLA is partnered with [[:pharmaceutical_companies:Actelion]] (now a [[:pharmaceutical_companies:Johnson & Johnson]] company), [[:pharmaceutical_companies:AstraZeneca]], [[:pharmaceutical_companies:Bayer]], [[:pharmaceutical_companies:Boehringer Ingelheim]], [[:pharmaceutical_industry:GlaxoSmithKline]], [[:pharmaceutical_companies:Grifols]], [[:pharmaceutical_companies:InterMune]], [[:McArthur Medical Sales]], [[:pharmaceutical_companies:Pediapharm]] (now called [[:pharmaceutical_companies:Medexus]]), [[:, [[:pharmaceutical_companies:Merck]], [[:pharmaceutical_companies:Novartis]], [[:pharmaceutical_companies:Pfizer]], [[:ProResp]], RBC ([[:Royal Bank of Canada]]), [[:pharmaceutical_companies:Roche]], [[:pharmaceutical_companies:Takeda]], and [[:Trudell Medical]].((//About Us.// (2014, August 21). Canadian Lung Association. https://archive.ph/XNGx1)) ((//2020/2021 Annual Report.// Lung Association of Canada. Retrieved January 10, 2022, from https://www.lung.ca/sites/default/files/LungAssociation_AnnualReport_2020_2021_EN_FIN.pdf)) ((//2019/2020 Annual Report.// Canadian Lung Association. Retrieved January 10, 2022, from https://www.lung.ca/sites/default/files/LungAssociation_AnnualReport_2019_2020_EN.pdf)) ((//2017/2018 Annual Report.// Canadian Lung Association. Retrieved January 10, 2022, from https://www.lung.ca/sites/default/files/CLA_AnnualReport2017_2018_EN_FINALSEPT21.pdf)) ((//2016/2017 Annual Report.// Canadian Lung Association. Retrieved January 10, 2022, from https://www.lung.ca/sites/default/files/LungAssociation_AnnualReport_2016_2017_ENGLISHOCTOBER.pdf)) ((//2015/2016 Annual Report.// Canadian Lung Association. Retrieved January 10, 2022, from https://www.lung.ca/sites/default/files/LungAssociation_AnnualReport_2015_2016_EN.pdf))
==== University of Calgary ====

Walker is a Clinical Associate Professor of Medicine at the [[:University of Calgary]]'s Snyder Institute for Chronic Diseases (in partnership with [[Alberta Health Services]]).((//Brandie Walker.// (2021, February 25). Snyder Institute for Chronic Diseases. https://archive.ph/pOhJW))

Her research focus is in the field of airways diseases with a focus on COPD and asthma. 

===== Relationships with Pharmaceutical Companies =====

Through her participation in the [[:CanCOLD]] study, Walker has received funding from [[:pharmaceutical_companies:Almirall]], [[:pharmaceutical_companies:AstraZeneca]], [[:pharmaceutical_companies:Boehringer Ingelheim]], [[:pharmaceutical_companies:GlaxoSmithKline]], [[:pharmaceutical_companies:Merck]], [[:NeuMeDx]], [[:pharmaceutical_companies:Novartis]], [[:pharmaceutical_companies:Nycomed]], [[:pharmaceutical_companies:Pfizer]], [[:pharmaceutical_companies:Takeda]], and [[:pharmaceutical_companies:Theratechnologies]].((//Home.// CanCOLD. Retrieved January 9, 2022, from https://archive.ph/Bp2Fc))

===== External links =====

  * [[https://www.whiteroseintelligence.com/brandie-walker/|White Rose Wiki]]